NIM
VRTX icon

NuWave Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

NuWave Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-478
Closed -$87K – 426
2021
Q3 		$87K Sell
478
-1,515
-76% -$296K 0.1% 209
2021
Q2 		$402K Buy
1,993
+641
+47% +$134K 0.45% 71
2021
Q1 		$291K Buy
+1,352
New +$297K 0.37% 99
2020
Q4 		– Sell
-23
Closed -$6K – 532
2020
Q3 		$6K Sell
23
-944
-98% -$260K 0.01% 356
2020
Q2 		$275K Buy
+967
New +$262K 0.36% 81
2020
Q1 		– Sell
-3,586
Closed -$785K – 409
2019
Q4 		$785K Buy
3,586
+3,492
+3,715% +$707K 0.77% 29
2019
Q3 		$16K Sell
94
-128
-58% -$22.6K 0.02% 334
2019
Q2 		$41K Sell
222
-567
-72% -$99.1K 0.04% 239
2019
Q1 		$146K Buy
+789
New +$146K 0.17% 163
2018
Q4 		– Sell
-104
Closed -$20K – 429
2018
Q3 		$20K Buy
104
+100
+2,500% +$17.8K 0.03% 225
2018
Q2 		$1K Sell
4
-1,152
-100% -$179K ﹤0.01% 367
2018
Q1 		$184K Buy
1,156
+1,096
+1,827% +$179K 0.29% 112
2017
Q4 		$9K Buy
+60
New +$8.88K 0.01% 264
2014
Q3 		$148K Sell
1,318
-142
-10% -$13.5K 0.42% 89
2014
Q2 		$138K Buy
1,460
+565
+63% +$39.6K 0.36% 110
2014
Q1 		$63K Sell
895
-4,037
-82% -$320K 0.19% 152
2013
Q4 		$367K Sell
4,932
-12,159
-71% -$847K 0.32% 114
2013
Q3 		$1.29M Buy
17,091
+14,199
+491% +$1.13M 1.18% 21
2013
Q2 		$232K Buy
+2,892
New +$213K 0.25% 119

Other funds holding VRTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

NuWave Investment Management's VRTX Position: Q4 2021 in Review

NuWave Investment Management sold out of Vertex Pharmaceuticals (VRTX) in Q4 2021, closing a stake of 478 shares — an estimated $87K sold.

NuWave Investment Management first reported a position in VRTX in Q2 2013 and held it in 19 quarters. The position peaked at $1.29M in Q3 2013. 1,034 funds tracked by Wall St. Rank hold VRTX as of Q4 2021.

  • NuWave Investment Management reported no remaining Vertex Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • NuWave Investment Management sold 478 Vertex Pharmaceuticals shares in Q4 2021, an estimated $87K.
  • NuWave Investment Management first reported a position in Vertex Pharmaceuticals in Q2 2013 and held it in 19 quarters.
  • NuWave Investment Management's Vertex Pharmaceuticals position peaked at $1.29M in Q3 2013.
  • 1,034 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2021.

Based on NuWave Investment Management's 13F filing for Q4 2021, filed 18 Jan 2022.